BMI has been the benchmark in evaluating health and fitness for many years. The formula is quite simple: weight in kilograms divided by the square of height in meters. This would easily tell if one is underweight, within the healthy weight range, overweight, or obese. But with new research findings, scientists are now questioning its accuracy and usefulness as a total measure of body composition.

The report, published in The Lancet Diabetes & Endocrinology, has sparked a global conversation on rethinking BMI. Supported by more than 50 international medical experts, the report suggests classifying obesity into "clinical" and "pre-clinical" types for better diagnosis and treatment. The shift underscores a growing consensus: BMI alone may not tell the full story of your health.

While BMI is simple to calculate and universally accessible, it is far from perfect. It does not consider muscle mass, bone density, or fat distribution, leading to misleading conclusions in some cases. For example, athletes with a high muscle mass may be considered overweight, whereas individuals with normal BMI might carry unhealthy amounts of visceral fat.

A landmark study in JAMA Network Open studied more than 155,000 postmenopausal women and found that women with a normal BMI but a waist size over 35 inches were more likely to die from heart disease or cancer compared with their counterparts whose waists are smaller. That makes a great case for how BMI can be insufficient and fat distribution must be factored into account.

Not all body fat is equal. Subcutaneous fat, which lies just beneath the skin, is relatively harmless. The real health danger lies in visceral fat—fat that surrounds internal organs. Unlike subcutaneous fat, visceral fat is metabolically active, releasing stress hormones like cortisol and inflammatory substances that raise blood pressure, blood sugar, and cholesterol levels. These effects significantly increase the risk of conditions such as heart disease, type 2 diabetes, and certain cancers.

BMI Isn't Always the Best Measure of Body Composition — Here's What to Use Instead

Since BMI is not the most reliable measure, scientists and doctors have sought other means to measure body composition more accurately.

1. Waist Circumference

A simple tape measure can provide valuable insight into your health. Measure your waist at the level of your belly button, ensuring the tape is parallel to the ground. For women, a waist measurement under 35 inches is considered healthy, while for men, the goal is under 40 inches.

2. Waist-to-Hip Ratio

This is the ratio of your waist circumference to that of your hips. To calculate it, divide your waist measurement by your hip measurement. According to the National Center for Biotechnology Information, a ratio under 0.8 for women and 0.9 for men is considered healthy.

3. Body Roundness Index (BRI)

A newer method that seems to be receiving more attention involves the Body Roundness Index or BRI: height, weight, and girth are placed together to represent a more advanced view of what body composition says. Research presented in JAMA Network Open offers evidence that this BRI predicts mortality risk greater than BMI in some cases- a promising weapon for public health.

Also Read: Using BMI To Classify People As Obese Is Flawed Say Experts

Ways To Cut Off Unhealthy Fat

The good news is that visceral fat responds well to lifestyle changes. Here are three evidence-based strategies:

Time-Restricted Eating

Adopting an eating window of 12 hours—such as from 7 a.m. to 7 p.m.—can significantly reduce visceral fat, according to a study published in Nutrition Research Reviews. This approach not only helps control caloric intake but also reduces late-night snacking, a known risk factor for abdominal obesity.

Limit Alcohol Intake

Excessive alcohol consumption is associated with increased belly fat. A 2017 study published in Public Health Nutrition revealed that alcohol increases the levels of insulin and encourages the storage of fat in the abdominal area. Limiting alcohol to occasional indulgence helps avoid weight gain in this region.

High-Intensity Interval Training (HIIT)

HIIT involves repeated episodes of high-intensity exercise separated by periods of rest. A review in *Sports Medicine* concluded that HIIT is very effective in reducing visceral and total body fat. It can be noted that adding just 20 minutes of HIIT two times a week can make all the difference.

The reliance on BMI as a sole indicator of health is increasingly being challenged. While it remains a convenient screening tool, its limitations necessitate a broader approach that considers factors like fat distribution, waist circumference, and new metrics such as BRI.

In the simplest of words, health is multi-dimensional, and shifting perspectives from considering weight solely to broader measures of body composition will get people a much clearer understanding of where their health risks are so that they can take the action required for a better quality of life. Through adjustment to diet, exercise, or perhaps through innovative metrics like BRI, health is well within reach of the individual.

This dynamic conversation raises the point about personalized health screenings, which helps everyone get more relevant tools fitting their unique lives and circumstances. As body composition research is enhanced, so do the futures look brighter and brighter for the times of measurement when it comes to health.

Definition and diagnostic criteria of clinical obesity. The Lancet Diabetes & Endocrinology.

Association of Normal-Weight Central Obesity With All-Cause and Cause-Specific Mortality Among Postmenopausal Women. JAMA Netw Open. 2019

Waist-Hip Ratio. NIH.

Physiological responses to food intake throughout the day. Nutr Res Rev. 2014

Association between abdominal obesity and alcohol drinking pattern in normal-weight, middle-aged adults. Public Health Nutr. 2017

We have always been told that truly sustainable weight loss is a long-term process made up of daily physical activity, healthy eating, and regular sleep. However, a four-minute workout from Japan, which has taken social media by storm, has confidently challenged this idea.

Making an ambitious promise, the makers of the workout claim that one can lose around 5 kg in just one week with the 4-minute workout.

The video, which was reshared on social media, has crossed 3 million views on X, with nearly 60,000 likes, has sparked a debate whether the short routine could really replace a longer gym session.

The virality of the video makes sense. Most of us argue with ourselves everyday, trying to talk ourselves out of going to the gym and spending hours toiling away. But do we realistically need just a few minutes to get in shape?

You don't need dumbbells, gym membership, or any special equipment to do this workout routine. You can apparently do it almost anywhere.

Can You Actually Lose 5 Kg In 7 Days?

Also read: Novak Djokovic’s Health Struggles At US Open: Are The Demands Of Elite Tennis Becoming Too Much?

There is no evidence that four minutes of exercise a day can make someone lose 5 kg of body weight in seven days. The viral claim comes from the makers of the video, rather than a clinical study showing that people following the routine lost 5 kg in a week.

Experts also say that such a drastic amount of weight loss in seven days is not realistically achievable for most people.

Additionally, what appears on the weighing scale can also move up or down because of water retention, food in the digestive system, and other short-term changes. A sudden drop in weight therefore does not necessarily mean that 5 kg of body fat has disappeared.

Losing considerable body fat needs more than just a 'very short workout'. Along with at least 30 minutes of physical activity, one needs a sustained calorie deficit.

The Four Minutes Of Exercise Is Not Completely Useless

Also read: What Is Zone 2 Cardio? The Workout Everyone Is Talking About

Now as the facts are clear, we would be remiss to not appreciate the routine's biggest potential, which is getting inactive people to move, not weight loss.

Four minutes of activity is certainly better than spending those four minutes sitting still. If a short routine like this Japanese workout feels manageable enough to turn it into a daily habit, it can give you a starting point for physical activity, which you can gradually increase.

But one needs to be careful. A short workout routine usually makes your heart work harder. If you experience pain, dizziness, chest discomfort, or an irregular heartbeat, you must stop immediately.

People who are new to exercise or have existing health concerns should speak with a doctor before starting a new routine.

How To Lose Weight Safely?

Rather than trying to take a shortcut and achieve a drastic weight loss in less days, opt for a more sustainable approach is to gradually increase daily movement and combine it with a balanced diet.

Novak Djokovic, the 24-time Grand Slam champion, suffered his earliest Grand Slam exit in 20 years after crashing out in the first round of the US Open with a five-set defeat to Argentina’s Mariano Navone.

Djokovic was left in tears after bouts of vomiting, cramping and pain. He also relied on multiple medical timeouts, an inhaler and pills to stay on the court.

“I despised every moment I was on the court,” Djokovic told the media after the match, adding that he had been dealing with similar issues throughout the season.

“I think it was obvious that it was an awful feeling on the court for me. It’s something that I’ve been carrying, unfortunately, pretty much every match this year,” he said.

Djokovic described how his body broke down during the match.

“Vomiting, throwing up, a serious issue there. Then my whole body starts to collapse, basically cramping and pain. The back just gave up in the end and my shoulder, and I couldn’t close it out,” he added.

The defeat ended Djokovic’s hopes of winning a 25th Grand Slam title at this year’s US Open.

Also read: 47-Year-Old Assam Doctor Dies After Collapsing In The Gym: When Can Exercise Trigger A Cardiac Emergency?

Similar Struggles In Cincinnati

Earlier this month at the Cincinnati Open, Djokovic, who holds the all-time men’s record of 428 weeks as world No. 1 in singles, also struggled physically throughout his second-round match.

The 39-year-old was seen crouching on all fours between points, required a medical timeout and appeared to vomit into towels as extreme heat and humidity took a toll.

He then suffered a surprising second-round defeat, losing to Argentina’s Thiago Agustín Tirante 2-6, 6-4, 6-4.

Following the defeat, Djokovic revealed that he had been dealing with a longstanding health condition that becomes particularly difficult to manage in hot and humid conditions.

“It’s because of a health issue I have,” Djokovic told reporters after the match. “I’ve been dealing with it for many years now. It causes me a lot of problems, especially when there’s a lot of humidity and heat.”

Is Elite Tennis Becoming Too Demanding?

Read More: What Keeps Messi and Ronaldo Biologically Younger Than Their Age? Experts Explain

Djokovic is not alone in facing physical challenges. His exit comes after world No. 1 Jannik Sinner withdrew from the tournament due to injury, while defending champion Carlos Alcaraz entered the event after a long break.

Other names include Italy’s Lorenzo Musetti and France’s Arthur Fils who missed earlier Grand Slams in 2026 with injuries, and No. 2 seed Elena Rybakina managing a heel injury ahead of her opener.

Together, these developments raise a broader question: Are the demands of elite tennis becoming too much for even the world’s best players?

While Djokovic has not revealed the nature of his illness, he told reporters that he is “trying” to address the ailment.

Age, Recovery And The Demands Of Tennis

In 2023, Djokovic acknowledged that his body was beginning to feel the effects of a long career, although he still felt he had fuel left in the tank.

“The desire is still there, but things can change quickly – I am 36, I’ve been a pro for 20 years.”

He said he did not view age as a decisive factor, instead focusing on his overall physical condition and whether he continued to enjoy playing.

Age can affect tennis performance through changes such as reduced muscle mass, slower recovery and lower aerobic capacity, which can also increase injury risk.

Year-round Tours, Extreme Heat

In addition to performance pressures, the grueling schedules of the ATP and WTA Tours that span nearly 11 months of the year, give athletes limited time to rest and recover from injuries.

At the same time, rising global temperatures and intense matches lasting up to five hours have added further physical challenges.

“We’re losing the battle overall despite the advances in sports medicine,” Neeru Jayanthi, who leads the tennis medicine programme at Emory Healthcare in Atlanta, told The Straits Times.

Along with creating new avenues for managing type 2 diabetes and metabolic health, GLP-1 drugs like Ozempic, Wegovy, Mounjaro, and Zepbound are also transforming the weight loss game.

Despite its striking benefits in tackling obesity, it poses the risk of significant muscle loss as it works by reducing appetite rather than burning energy.

To address this issue, researchers at the University of California, Berkeley have identified an experimental compound. It could offer a very different approach to weight loss that may not result in excessive muscle loss.

How Was The Study Conducted?

The compound, called 5-tetradecyloxy-2-furoic acid, or TOFA, is not approved as a weight-loss treatment and has so far only been tested in animals. Weight loss is the result of mainly two bodily mechanisms: Taking in fewer calories than the amount burned during a specific period.

Since GLP-1 drugs only focus on the first part, the resultant weight loss also includes loss of lean muscle mass. TOFA is developed to increase the amount of energy burned rather than just supressing appetite.

Anders Näär, professor of metabolic biology and nutrition at UC Berkeley and senior author of the study, explained, "Body weight responds to two levers: taking in fewer calories or spending more energy. GLP-1s work almost entirely on the first, so we went after the second."

When tested on mice, it increased energy use by as much as 18% without making the animals more physically active or raising their body temperature. The mice lost body fat without a significant reduction in lean muscle mass.

Also read: US FDA Approves Eli Lilly’s Mounjaro To Reduce Cardiovascular Risk In Diabetics

How Does TOFA Compound Work?

TOFA belongs to a group of compounds known as ACC inhibitors. It interferes with the production of lipids like cholesterol and triglycerides while also activating cells involved in utilising fat as fuel.

Researchers found that TOFA activated PPARα and PPARδ, receptors that switch on genes involved in fat uptake and energy expenditure. Justin Y. Lee, the study's first author, said, “TOFA appears to engage a coordinated metabolic response.”

He added, “It is not simply blocking lipid synthesis. It is also activating energy expenditure pathways that may help the body handle excess lipid and glucose more effectively.”

The mice also showed improvements in insulin sensitivity, blood glucose, triglycerides, and signs of fatty liver disease.

Also read: Unapproved Weight-Loss Drug Caused Hospitalisations In Ireland: What Is Retatrutide & Why Is It Risky?

Could TOFA Be Combined With Ozempic Or Mounjaro?

The researchers tested TOFA alongside GLP-1 drugs including semaglutide and tirzepatide. In mice, the combinations produced greater improvements in body weight, glucose control, insulin levels, and triglycerides than either treatment alone.

Näär said, “TOFA worked additively or synergistically with the GLP-1 appetite-suppressing drugs, so we view it as complementary rather than as a replacement.”

In other words, researchers are looking to maximise the benefits of the two-pronged approach: One drug could dial your appetite down while another could turn up energy expenditure.

Despite promising results, we have to take a pause as TOFA is not yet an approved human weight-loss drug, meaning researchers do not yet know whether the compound will produce the same effects, or whether it will be safe, in humans.